Home › Articles
🧬
Medication safety

MDR1: Why Some Herding Breeds React Badly to Ordinary Drugs

Quick answer

An ABCB1 gene variant, commonly called MDR1, can reduce a dog's ability to keep certain drugs out of the brain or eliminate them normally. Breed ancestry can suggest who should be tested, but only an individual genetic result and a veterinarian's drug-specific plan can define the precautions for that dog.

Last updated September 13, 2026

MDR1 and ABCB1 describe the same safety problem

MDR1 is the older, familiar name for a gene now called ABCB1. It produces P-glycoprotein, a transport protein that helps limit movement of certain drugs into the brain and assists their removal from the body. Washington State University's College of Veterinary Medicine explains that a variant can leave this protection defective and allow some drugs to reach harmful concentrations.

The result is not a general allergy to medicine. Sensitivity is drug-specific: one medication may require avoidance or an adjusted plan, another may be used with veterinary precautions, and many drugs are not affected by the variant. A list copied from social media cannot replace the current problem-drug guidance and the prescribing veterinarian's assessment.

The human medicine guide remains the safer starting point for accidental access. MDR1 status does not turn an unapproved human medicine into an appropriate home treatment.

Breed ancestry is a reason to test, not a diagnosis

WSU reports the variant most often in herding-breed lineages and also in Longhaired Whippets and Silken Windhounds. Its published breed list includes Collies, Australian Shepherds, Miniature American Shepherds, Shetland Sheepdogs, Old English Sheepdogs, German Shepherds and several related breeds. Mixed-breed dogs can carry the variant when affected ancestry is present.

Appearance cannot establish genotype. A Collie-looking dog may test normal, while a mixed-breed dog without an obvious herding appearance may carry a copy. WSU emphasizes that testing is the only way to know an individual dog's status. Treat breed percentages as population information, not as the dog's result.

The breed and size toxicity guide explains the wider principle: breed and weight can alter risk, but neither predicts a complete clinical outcome by itself.

If the result is not known, tell the veterinarian the dog's known or possible breed ancestry before a new prescription, anesthesia plan or treatment for a toxic exposure. The team can decide whether testing or an interim precaution is appropriate.

What a genetic result can say

Use the laboratory's exact wording because terms such as carrier, mutant/normal and affected can be presented differently. Ask the veterinarian to interpret the report in the context of the specific medication and reason it is being considered.

Result conceptWhat it supportsWhat it does not prove
No variant detectedThe tested ABCB1 variant was not foundThat every drug or dose is safe, or that no other health factor matters
One variant copyThe dog can pass the variant and may have drug sensitivityA fixed response to every listed drug
Two variant copiesHigher concern for defective P-glycoprotein functionThat treatment is impossible or every medication must be avoided
Unknown or pendingBreed history and current condition can guide interim cautionPermission to guess the result from appearance

Medication categories that deserve an MDR1 check

WSU's current problem-drug list includes loperamide, certain sedatives and pain medicines, some chemotherapy drugs, and several antiparasitic drugs when used in particular formulations or at higher exposure levels. The clinical decision is not identical across that list. For example, WSU distinguishes approved low-dose heartworm prevention from higher-dose or concentrated ivermectin exposures.

Some flea and tick medicines attract online concern simply because they treat parasites. WSU states that it has no evidence of increased toxicity for several commonly used isoxazoline products in dogs with the variant. That does not remove the need to use the correct species, weight band and label or to report a prior seizure history.

Do not turn a problem-drug list into a dosing chart. Formulation, route, other medicines, liver and kidney function, age, illness and treatment goal all influence the plan. Ask about the exact generic and brand name rather than whether “anesthesia” or “dewormer” is safe in the abstract.

Accidental exposure still needs ordinary poison triage

If a dog eats a medicine, collect the package, strength, amount missing, time and current signs, then call. State the MDR1 result—or that it is suspected—at the beginning. Do not wait for a genetic test before seeking help for an active exposure.

Possible neurologic signs after a relevant drug can include marked sleepiness, poor coordination, tremors, seizures, blindness-like behavior or coma, but signs vary by drug and amount. Collapse, seizures, breathing changes or inability to stand require emergency veterinary care.

Use the poison-control call checklist to prepare the handoff. Never give another medicine to counteract the exposure unless the treating professional directs it.

Turn the result into a durable safety record

A wallet card or collar tag can say “ABCB1/MDR1 result on file—contact veterinarian” without trying to list every drug. Lists change as evidence develops, while the laboratory report remains the clearest statement of the dog's genotype.

  • Give the report to the regular veterinarian and every specialty or emergency clinic involved in care.
  • Place the result in the medical record under both ABCB1 and MDR1 so either search term finds it.
  • Keep a photograph or PDF on the phones of the people who transport or care for the dog.
  • Mention the result before prescriptions, procedures, anesthesia, parasite treatment and poison-exposure care.
  • Ask the veterinarian to review the current WSU problem-drug list when a relevant medicine is considered.
  • Tell breeders about a confirmed variant so reproductive decisions can be made with appropriate genetic advice.
Animal poison control, 24/7

Frequently asked questions

Is MDR1 the same as ABCB1?

In this context, yes. MDR1 is the older name commonly used for the canine drug-sensitivity variant in the gene now called ABCB1, which codes for the P-glycoprotein transporter.

Which dog breeds can have the MDR1 variant?

It is most associated with herding-breed lineages and also occurs in Longhaired Whippets and Silken Windhounds. Mixed breeds can carry it. WSU's breed list can guide testing, but appearance cannot diagnose an individual.

Can an MDR1 dog take heartworm prevention?

WSU distinguishes label-approved low-dose heartworm prevention from higher-dose or concentrated exposures. Do not generalize between products or uses; have the veterinarian select the exact product and plan.

Does a normal test mean every medicine is safe?

No. It answers one genetic question. The dog's diagnosis, dose, formulation, other medicines and organ function still matter, and any medicine can have adverse effects unrelated to ABCB1.

Can I use breed percentages instead of testing?

No. Population frequency cannot reveal one dog's genotype. WSU states that testing is the only way to know the individual result.

What should I do if my drug-sensitive dog ate medicine?

Call a veterinarian or animal poison-control service with the package, strength, amount, time, weight, signs and MDR1 report. Do not induce vomiting or give another drug unless specifically directed.

Sources: Washington State University: MDR1 overview; Washington State University: MDR1 in dogs; Washington State University: Breeds commonly affected by the MDR1 mutation. This article is general information, not a substitute for veterinary advice. If your dog is in distress, contact your veterinarian or an emergency animal hospital immediately.